Log In
Print
BCIQ
Print
Print this Print this
 

Topicort, desoximetasone

  Manage Alerts
Collapse Summary General Information
Company Taro Pharmaceutical Industries Ltd.
DescriptionCorticosteroid spray containing 0.25% desoximetasone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationPsoriasis
Indication DetailsTreat plaque psoriasis in adults
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today